Mini Review - Research on Chronic Diseases (2022) Volume 6, Issue 4

How Is Chronic Obstructive Pulmonary Disease Managed? And Its Treatment and Surgery

Hayfa Almutary*

Department of Nursing, University of Queensland of Technology, Australia



*Corresponding Author:
Hayfa Almutary Department of Nursing, University of Queensland of Technology, Australia



Received: 01-Jul-2022, Manuscript No. oarcd-22-70607; Editor assigned: 04-Jul-2022, PreQC No. oarcd-22-70607 (PQ); Reviewed: 18-Jul-2022, QC No. oarcd-22-70607; Revised: 21-Jul-2022, Manuscript No. oarcd-22-70607 (R); Published: 28-Jul-2022, DOI: 10.37532/ rcd.2022.6(4).78-81


Habitual obstructive pulmonary complaint( COPD) is a common, preventable and treatable habitual lung complaint which affects men and women worldwide. Abnormalities in the small airways of the lungs lead to limitation of tailwind in and out of the lungs. Several processes beget the airways to come narrow. There may be destruction of corridor of the lung, mucus blocking the airways, and inflammation and lump of the airway filling.COPD is occasionally called emphysema or habitual bronchitis. Emphysema generally refers to destruction of the bitsy air sacs at the end of the airways in the lungs. habitual bronchitis refers to a habitual cough with the product of numbness performing from inflammation in the airwaysCOPD and asthma share common symptoms( cough, blow and difficulty breathing) and people may have both conditions.


COPD is an marquee term for a range of progressive lung conditions. Habitual bronchitis and emphysema can both affect in COPD. A COPD opinion means you may have one of these lung- damaging conditions or symptoms of both. COPD can progress gradationally, making it harder to breathe over time [1]. COPD treatment focuses on relieving symptoms, similar as coughing and breathing problems, and avoiding respiratory infections. Your provider may recommend [2].

• Bronchodilators These drugs relax airways. You gobble a mist containing bronchodilators that help you breathe easier.

• Anti-inflammatory specifics You gobble steroids or take them as a lozenge to lower inflammation in the lungs.

• Supplemental oxygen If blood oxygen is low( hypoxemia), you may need a movable oxygen tank to ameliorate your oxygen situations.

• Antibiotics COPD makes you prone to lung infections, which can further damage your weakened lungs. You may need to take antibiotics to stop a bacterial infection.

Vaccinations Respiratory infections are more dangerous when you have COPD. It’s especially important to get shots to help flu and pneumonia [3].

• Rehabilitation programs educate effective breathing strategies to lessen briefness of breath and on exertion. When maintained, fitness can increase the quantum you can do with the lungs you have.

• Anticholinergics These medicines relax the muscle bands that strain around the airways and help clear mucus from the lungs. Relaxed muscles let further air in and out. With the airways open, the mucus moves further freely and can thus be coughed out more fluently. Anticholinergics work else and more sluggishly than presto- acting bronchodilators [4].

• Leukotriene modifiers these specifics affect leukotrienes, chemicals that do naturally in the body that beget tightening of airway muscles and product of mucus and fluid. Leukotriene modifiers block the chemicals and drop these responses, helping ameliorate tailwind and reducing symptoms in some people [5].

• Expectorants These products thin mucus in the airways so you can cough it out more fluently. You should take these specifics with about 8 ounces of water.

• Antihistamines These drugs relieve stuffy heads, watery eyes, and sneezing. Although effective at relieving these symptoms, antihistamines can dry the air passages, making breathing delicate, as well as causing difficulty when coughing up redundant mucus. Take these specifics with food to reduce worried stomach [6].

Antivirals Your provider might define these to treat or help ails caused by contagions, utmost constantly to treat or help influenza (“the flu”). Influenza is particularly dangerous for people who have COPD [7].


There’s no cure for COPD. still, treatments can help with symptoms, decelerate the progress of the complaint, and ameliorate your capability to stay active. There are also treatments to help or treat complications of the complaint. Treatments include

Lifestyle changes, similar as

• Quitting smoking if you’re a smoker. This is the most important step you can take to treat COPD [8].

• Avoiding secondhand bank and places where you might breathe in other lung irritants

• Ask your health care provider for an eating plan that will meet your nutritive requirements. Also ask about how important physical exertion you can do. Physical exertion can strengthen the muscles that help you breathe and ameliorate your overall heartiness [9].

Medicines, similar as

• Bronchodilators, which relax the muscles around your airways. This helps open your airways and makes breathing easier. utmost bronchodilators are taken through an inhaler. In more severe cases, the inhaler may also contain steroids to reduce inflammation [10].

• Vaccines for the flu and pneumococcal pneumonia, since people with COPD are at advanced threat for serious problems from these conditions

• Antibiotics if you get a bacterial or viral lung infection

Oxygen remedy, if you have severe COPD and low situations of oxygen in your blood. Oxygen remedy can help you breathe more. You may need redundant oxygen all the time or only at certain times [11].

Pulmonary recuperation, which is a program that helps ameliorate the well- being of people who have habitual breathing problems. It may include

• An exercise program

• Disease operation training

• nutritive comforting

• Cerebral comforting

Surgery, generally as a last resort for people who have severe symptoms that haven’t gotten better with drugs

• For COPD that’s substantially related to emphysema, there are surgeries that [12]

• Remove damaged lung towel

• Remove large air spaces( bullae) that can form when air sacs are destroyed. The bullae can intrude with breathing.

• For severe COPD, some people may need lung transplant

Still, it’s important to know when and where to get help for your symptoms, If you have COPD. You should get exigency care if you have severe symptoms, similar as trouble catching your breath or talking. Call your health care provider if your symptoms are getting worse or if you have signs of an infection, similar as a fever [13,14].


Surgery is reserved for severe COPD or when other treatments have failed, which is more likely when you have a form of severeemphysema.One type of surgery is called bullectomy. During this procedure, surgeons remove large, abnormal air spaces( bullae) from the lungs [15].

Another is lung volume reduction surgery, which removes damaged upper lung towel. Lung volume reduction surgery can be effective at perfecting breathing, but many cases suffer this major, kindly parlousprocedure.Lung transplantation is an option in some cases. Lung transplantation can effectively cure COPD, but has its numerousrisks.There’s a less invasive system of perfecting the effectiveness of tailwind in people with severe emphysema called endobronchial faucets( EBV), which are oneway faucets that divert inspired air to healthy lungs and down fromnon-functioning, damaged lungs [16].

Emphysema is a condition in which the alveoli at the end of the lowest air passages( bronchioles) of the lungs are destroyed as a result of dangerous exposure to cigarette bank and other prickly feasts and particulate matter.

Although COPD is a progressive complaint that gets worse over time, COPD is treatable. With proper operation, utmost people with COPD can achieve good symptom control and quality of life, as well as reduced threat of other associated conditions [17].

The main cause of COPD in advanced countries is tobacco smoking. In the developing world, COPD frequently occurs in people exposed to smothers from burning energy for cuisine and heating in inadequately voiced homes [18].

Only some habitual smokers develop clinically apparent COPD, although numerous smokers with long smoking histories may develop reduced lung function. Some smokers develop less common lung conditions. They may be misdiagnosed as having COPD until a more thorough evaluation is performed.

Causes of airway inhibition include

• Emphysema. This lung complaint causes destruction of the fragile walls and elastic filaments of the alveoli. Small airways collapse when you exhale, injuring tailwind out of your lungs.

• habitual bronchitis. In this condition, your bronchial tubes come inflamed and narrowed and your lungs produce further mucus, which can further block the narrowed tubes [19]. You develop a habitual cough trying to clear your airways.

Threat factors for COPD include

• Exposure to tobacco bank. The most significant threat factor for COPD is longterm cigarette smoking. The further times you bomb and the further packs you bomb, the lesser your threat. Pipe smokers, cigar smokers and marijuana smokers also may be at threat, as well as people exposed to large quantities of secondary bank [20].

• People with asthma. Asthma, a habitual seditious airway complaint, may be a threat factor for developing COPD. The combination of asthma and smoking increases the threat of COPD indeed more.

• Occupational exposure to dusts and chemicals. Long- term exposure to chemical smothers, vapors and dusts in the plant can irritate and inflame your lungs.

• Exposure to smothers from burning energy. In the developing world, people exposed to smothers from burning energy for cuisine and heating in inadequately voiced homes are at advanced threat of developing COPD.

• Genetics. The uncommon inheritable complaint nascence-1-antitrypsin insufficiency is the cause of some cases of COPD. Other inheritable factors probably make certain smokers more susceptible to the complaint.


In 2018, an EBV device called the Zephyr Endobronchial ValveTrusted Source was approved by the FDA and has been shown to ameliorate lung function, exercise capacity and quality of life for cases living with emphysema. habitual obstructive pulmonary complaint( COPD) is a habitual seditious lung complaint that causes dammed tailwind from the lungs. Symptoms include breathing difficulty, cough, mucus( foam) product and gasping. It’s generally caused by long- term exposure to prickly feasts or particulate matter, most frequently from cigarette bank. People with COPD are at increased threat of developing heart complaint, lung cancer and a variety of other conditions. Emphysema and habitual bronchitis are the two most common conditions that contribute to COPD. These two conditions generally do together and can vary in inflexibility among individualities with COPD. Chronic bronchitis is inflammation of the filling of the bronchial tubes, which carry air to and from the air sacs(alveoli) of the lungs. It’s characterized by diurnal cough and mucus( foam)production.



Conflict of Interest

There is no Conflict of Interest.


  1. Vestbo J, Hurd SS, Agustí AG et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 187, 347-365 (2013).
  2. Google Scholar, Crossref, Indexed at

  3. Van Eerd EA, van der Meer RM, van Schayck OC et al. Smoking cessation for people with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2019, CD010744 (2016).
  4. Google Scholar, Crossref, Indexed at

  5. Tønnesen P. Smoking cessation and COPD. European Respiratory Review. 22, 37-43 (2013).
  6. Google Scholar

  7. Jiménez Ruiz CA, Fagerström KO. Smoking cessation treatment for COPD smokers: the role of counselling. Monaldi Archives for Chest Disease. 79, 33-37 (2013).
  8. Google Scholar, Crossref, Indexed at

  9. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 187, 350-352 (2013).
  10. Google Scholar, Crossref, Indexed at

  11. Tyagi J, Moola S, Bhaumik S et al. (2021) Diagnostic accuracy of screening tools for chronic obstructive pulmonary disease in primary health care: Rapid evidence synthesis. Fam Med Prim Care. 10, 2184-2194.
  12. Google Scholar, Crossref, Indexed at

  13. Williams N. The MRC breathlessness scale. Occup Med Lond. 67, 496-497 (2017).
  14. Google Scholar, Crossref, Indexed at

  15. Bailey KL. The importance of the assessment of pulmonary function in COPD. Med Clin North Am. 96, 745-752 (2012).
  16. Google Scholar, Crossref, Indexed at

  17. Qaseem A, Wilt TJ, Weinberger SE et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 155, 179-191 (2011).
  18. Google Scholar, Crossref, Indexed at

  19. Cooper CB. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med. 119, 21-31 (2006).
  20. Google Scholar, Crossref, Indexed at

  21. Calverley PM, Koulouris NG. Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology. Eur Respir J. 25, 186-199 (2005).
  22. Google Scholar, Crossref, Indexed at

  23. Higham A, Quinn AM, Cançado JE et al. The pathology of small airways disease in COPD: historical aspects and future directions. Respir Res. 20, 49 (2019).
  24. Google Scholar, Crossref, Indexed at

  25. Lo Bello F, Ieni A, Hansbro PM et al. Role of the mucins in pathogenesis of COPD: implications for therapy. Expert Rev Respir Med. 14, 465-483 (2020).
  26. Google Scholar, Crossref, Indexed at

  27. D'Ascanio M, Viccaro F, Calabrò N et al. Assessing Static Lung Hyperinflation by Whole-Body Plethysmography, Helium Dilution, and Impulse Oscillometry System (IOS) in Patients with COPD. Int J Chron Obstruct Pulmon Dis. 15, 2583-2589 (2020).
  28. Google Scholar, Crossref, Indexed at

  29. Capron T, Bourdin A, Perez T et al. COPD beyond proximal bronchial obstruction: phenotyping and related tools at the bedside. Eur Respir Rev. 28, 190010 (2019).
  30. Google Scholar, Crossref, Indexed at

  31. Maselli DJ, Bhatt SP, Anzueto A, et al. Clinical Epidemiology of COPD: Insights From 10 Years of the COPDGene Study. Chest. 156, 228-238 (2019).
  32. Google Scholar, Crossref, Indexed at

  33. Brode SK, Ling SC, Chapman KR et al. Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease. CMAJ. 184, 1365-1371 (2012).
  34. Google Scholar, Crossref, Indexed at

  35. Mortensen J, Berg RM. Lung Scintigraphy in COPD. Semin Nucl Med. 49, 16-21. (2019).
  36. Google Scholar, Crossref, Indexed at

  37. Klooster K, Slebos DJ. Endobronchial Valves for the Treatment of Advanced Emphysema. Chest. 159, 1833-1842 (2021).
  38. Google Scholar, Crossref, Indexed at

  39. Duffy S, Marchetti N, Criner GJ et al. Surgical Therapies for Chronic Obstructive Pulmonary Disease. Clin Chest Med. 41, 559-566 (2020).
  40. Google Scholar, Crossref, Indexed at